MINIVELLE Reviews (ESTRADIOL)

Average Rating: 4.0 (1 Ratings)

Filter Results

Compare MINIVELLE with similar:

 Type: Rx Drug

  

MINIVELLE  (ESTRADIOL):  This medication is a female hormone (estrogen). It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment.   FDA Approval Date: 2012-10-29 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR MINIVELLECOMMENTSSEXAGEDURATION/
DOSAGE		DATE ADDED
 
 4  Hot flashes, insomnia Weight gain, enlarged breasts I sleep much better and the hot flashes are nearly gone. I cut the patches in half several months ago. Weight gain stopped but I haven't been able to lose the extra 10 lbs. despite eating better and regular fitness. F 52 2 years
.0375		 12/28/2015
Email
  

MINIVELLE  (ESTRADIOL):  This medication is a female hormone (estrogen). It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment.   FDA Approval Date: 2012-10-29 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP